Article ID Journal Published Year Pages File Type
5698046 Clinical Oncology 2017 8 Pages PDF
Abstract
Physical and psychological symptoms assessed by ESAS were comparable in CN-mCRPC men treated with AA or EZ in the real-world clinical setting. Further studies are warranted to confirm these findings.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Impact of Abiraterone Acetate and Enzalutamide on Symptom Burden of Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer
Authors
, , , , , , ,